FDA Propels Insulin Affordability with Semglee

This content originally appeared on diaTribe. Republished with permission. By Karena Yan, Joseph Bell, and Arvind Sommi Semglee may provide a cheaper alternative to Lantus (insulin glargine) – it costs $148 for five pre-filled insulin pens. Semglee, which was approved last year as a new basal insulin for adults and children with type 1 diabetes […]

Review of TempraMed VIVI Cap 1: Reusable Insulin Cooler Cap

The TempraMed VIVI Cap 1 is a reusable insulin cap cooler that promises to keep your insulin safe in extreme weather – protecting it from both hot and cold. Your insulin won’t overheat, and it won’t freeze. This is a great tool for the hot summer months or the dead of the winter. Wouldn’t you […]

Insulin at 100, Part 3: Insulin’s Uncertain Future

This content originally appeared on diaTribe. Republished with permission. This is Part 3 of James S. Hirsch’s exploration of the riveting history of insulin, on the occasion of its 100th birthday. Part 1: The Discovery Part 2: Failed Promises, Bold Breakthroughs Insulin’s Uncertain Future Image source: Emily Ye, Diabetes Daily As further refinements in insulin […]

Insulin at 100, Part 2: Failed Promises, Bold Breakthroughs

This content originally appeared on diaTribe. Republished with permission. By James S. Hirsch Image source: diaTribe The discovery of insulin in 1921 was heralded as the cure for diabetes. The reality was different. Insulin, to be sure, could temporarily lower blood sugars to near-normal ranges, but it could also cause hypoglycemia – blood sugars that […]

How to Lose Weight and Be Active With Type 1 Diabetes

Editor’s Note: Cliff Scherb, Founder of the Glucose Advisors Consulting community and Tristar Athletes LLC, is a nutrition, health, and dosing expert. He consults virtually through the Glucose Advisors University, teaching the Scherb Method decision support system for insulin management, nutrition, weight loss, and activity. To inquire about program openings, courses, and general questions working […]

Mark Andrews: A Tight End with Type 1 Diabetes

This content originally appeared on Beyond Type 1. Republished with permission. By Katie Doyle The Baltimore Ravens didn’t choose just any offensive lineup during the 2018 NFL draft – a key part of their strategy is Mark Andrews, a tight end from the University of Oklahoma who has been managing his type 1 diabetes since […]

Semglee, A Low-Cost Basal Insulin, Comes to the US

This content originally appeared on diaTribe. Republished with permission. By Karena Yan and Joseph Bell A more affordable alternative to Lantus (insulin glargine) will cost $148 for five pre-filled insulin pens Mylan and Biocon Biologics announced last month the long-awaited US launch of Semglee, a new insulin aiming to be deemed “biosimilar” to insulin glargine (basal insulin) […]

Is Healthcare Provider Knowledge of Diabetes Lacking?

People’s experiences with healthcare providers can vary widely. When it comes to living with diabetes, many people expect that their healthcare providers, even if they’re not specialists, will be at least somewhat knowledgeable about their health condition. Many have found however, that while endocrinologists and diabetes education specialists tend to be more attuned to the […]

The Biggest News in Diabetes Technology, Drugs, and Nutrition: Highlights from ADA 2020

This content originally appeared on diaTribe. Republished with permission. By Eliza Skoler, Jimmy McDermott, Matthew Garza, Divya Gopisetty, Frida Velcani, Emily Fitts, Karena Yan, Joseph Bell, and Rosalind Lucier The diaTribe team attended the 2020 ADA 80th Scientific Sessions to share several of the greatest highlights from the virtual conference! The American Diabetes Association (ADA) 80th Scientific Sessions was […]

How to Safely Transition to Multiple Daily Injections (MDI)

As the reality of living during a pandemic slowly starts to sink in, people are changing their expectations for what 2020 (and beyond!) looks like. Some people have delayed their weddings, or put plans for a baby on hold, and many people have lost their jobs. In the US, where health insurance is so intimately […]